Scientific Programme
Year 2021
September 2021


Abstract Title
Clinical strategies for severe, treatment refractory Obsessive-Compulsive Disorder amid COVID-19 Pandemic



Institute of Mental Health1

Background & Hypothesis

Amid the COVID-19 Pandemic, strategies had to be established to ensure patients with severe, treatment-refractory Obsessive-Compulsive Disorder (OCD) and other related disorders such as Body Dysmorphic Disorder (BDD) continued to receive continuous personalized care and treatment to prevent relapses and readmissions.  The dedicated multi-disciplinary clinical team strategized to provide thorough assessment and a range of gold-standard treatment options.  This paper describes these strategies and outcomes.


From August 20 to July 21, due to split team infection control measures, 22 patients were assessed and if accepted, reviewed via Telehealth by the doctor whilst psychologist and case manager (CM) assessed patient face to face in clinic. The psychologist administered the Yales Brown Obsessive Compulsive Scale (YBOCS), the case manager administered Obsessive Compulsive Inventory-Revised (OCI-R), Patient Health Questionnaire (PHQ-9), Quality of Life Enjoyment and Satisfaction Questionnaire – Short Form (QLES-SF), as well as the EQ-5D-5L.  She followed up her patients with telephonic case management.


8 patients were discharged back to the referring doctor due to the following reasons – patient’s request, not keen/motivated for intensive therapy sessions, does not have a diagnosis of OCD, referred for second opinion. However, of the remaining 14 patients, only 1 was admitted for depression. Overall in this cohort, 3 patients showed significant reduction in OCD symptoms within the first 3 months of intensive therapy despite poor prognosis and 11 patients remain stable

Discussion & Conclusion

In conculsion, the OCD services effectively adapted and successfully provide treatment to treatment resistant, severe OCD patients through telehealth and telephonic case management.